CMS plans to exclude physician practices participating in the Oncology Care Model from the Part B drug demonstration, lobbyists for drug makers and providers said. Excluding those oncologists would improve the integrity of results from the Part B demo, but the carve out also could serve to ease the nerves of Democratic lawmakers who are caught between aggressive provider lobbyists trying to kill the demo and an administration that is urging Democrats against criticizing the Part B demo, sources say...